Related Experiment Video
Updated: Feb 23, 2026
04:30
Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
Published on: March 8, 2024
1.7K
[Diagnostic problems in patients with myasthenia gravis]
D Lavrnić1, V Rakocević-Stojanović, I Tripković
1Institute of Neurology, Clinical Centre of Serbia, Belgrade.
Srpski Arhiv Za Celokupno Lekarstvo
|November 23, 2000
Summary
Diagnosing myasthenia gravis (MG) often involves delays and errors. This study analyzed diagnostic challenges in MG patients, highlighting the need for improved diagnostic strategies to reduce delays and misdiagnoses.
Area of Science:
- Neurology
- Immunology
- Autoimmune Diseases
Context:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission.
- Antibodies against nicotinic acetylcholine receptors (nAChR) cause muscle weakness and fatigue.
- Early MG symptoms are frequently missed, leading to diagnostic delays.
Purpose:
- To analyze diagnostic errors and delays in myasthenia gravis patients.
- To identify challenges in the initial diagnosis of MG.
- To propose strategies for reducing diagnostic errors in MG.
Summary:
- A ten-year study (1983-1992) in Yugoslavia reviewed 444 MG patients.
- Correct initial diagnoses were made in 44.4% of cases; 38.4% received erroneous diagnoses.
- The average diagnostic delay for myasthenia gravis was 11 months.
Impact:
- Highlights significant diagnostic delays and errors in myasthenia gravis cases.
- Underscores the need for improved diagnostic strategies and awareness.
- Aims to reduce misdiagnosis and improve patient outcomes for MG.
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
366
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
366
01:26Chemical Synapses
4.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.8K
01:15Myasthenia Gravis: Diagnostic Tests
2.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.8K
01:20Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
01:28Disorders of the Skeletal Muscle
2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
01:26Chemical Synapses
12.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.1K